News for 'US Food and Drug Administration'

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Rediff.com6 Jan 2017

The BSE Midcap also cut all its intraday gains to shed 0.3% at close

Dr Reddy's: New launches to drive growth

Dr Reddy's: New launches to drive growth

Rediff.com28 Jun 2013

Analysts are eyeing bigger launches that will positively impact company's fortunes.

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Rediff.com14 Aug 2022

Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.

FSSAI-approved lab finds Maggi noodles safe

FSSAI-approved lab finds Maggi noodles safe

Rediff.com4 Aug 2015

Many countries found Maggi noodles to be safe for consumption.

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

Trump's health secy quits over plane scandal

Trump's health secy quits over plane scandal

Rediff.com30 Sep 2017

The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

Wockhardt: Recovery not in sight yet

Wockhardt: Recovery not in sight yet

Rediff.com5 Nov 2014

The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Piramal Enterprises to stop early-stage research

Piramal Enterprises to stop early-stage research

Rediff.com28 Aug 2014

To focus on molecules at advanced stage of development; move to impact 200 scientists.

Now, US FDA gets a call from Indian pharma companies

Now, US FDA gets a call from Indian pharma companies

Rediff.com27 Oct 2013

The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it

UK health regulator withdraws nod for another Wockhardt unit

UK health regulator withdraws nod for another Wockhardt unit

Rediff.com22 Oct 2013

The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.

'US FDA not on a witch hunt against India pharma firms'

'US FDA not on a witch hunt against India pharma firms'

Rediff.com23 Sep 2013

This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy

Why India's pharma cos prefer Gujarat over tax havens

Why India's pharma cos prefer Gujarat over tax havens

Rediff.com23 Sep 2017

Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Rediff.com6 May 2016

In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.

Sensex retreats from 6-week high, slides 253 points

Sensex retreats from 6-week high, slides 253 points

Rediff.com15 Mar 2016

Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.

States fail to find lead in Maggi noodles

States fail to find lead in Maggi noodles

Rediff.com19 Jun 2015

Test reports from UP food regulator started the controversy.

Nestl comes up with 'miss-you Maggi' ads

Nestl comes up with 'miss-you Maggi' ads

Rediff.com26 Aug 2015

The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.

Ranbaxy buy in line with Sun's strategy

Ranbaxy buy in line with Sun's strategy

Rediff.com17 Apr 2014

The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Richest self-made woman in America is now the poorest!

Richest self-made woman in America is now the poorest!

Rediff.com2 Jun 2016

Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.

Sensex, Nifty end in the red

Sensex, Nifty end in the red

Rediff.com16 Jun 2017

Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

From cow's milk to frozen veggies, Patanjali's product range gets wider

From cow's milk to frozen veggies, Patanjali's product range gets wider

Rediff.com14 Sep 2018

Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre

UP minister quits Yogi cabinet, may join Akhilesh; 3 MLAs follow him out

UP minister quits Yogi cabinet, may join Akhilesh; 3 MLAs follow him out

Rediff.com11 Jan 2022

Informing about his decision, Maurya said in a tweet in Hindi, 'Due to the attitude of gross neglect towards Dalits, backwards, farmers, unemployed youth and small and medium-sized traders, I am resigning from the council of ministers of Yogi (Adityanath) of UP.'

Wockhardt medicines banned in Europe

Wockhardt medicines banned in Europe

Rediff.com11 Jul 2013

Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.

Indian pharma cos shifting R&D to SE Asian countries

Indian pharma cos shifting R&D to SE Asian countries

Rediff.com4 Jul 2013

South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.

'No one is saying the vaccine is unsafe'

'No one is saying the vaccine is unsafe'

Rediff.com8 Jan 2021

'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

Now, a new treatment for ovarian cancer

Now, a new treatment for ovarian cancer

Rediff.com21 Jun 2014

Researchers claim to have developed a new treatment for ovarian cancer that can increase the rate of tumour shrinkage and prolong the time until cancers recur.

Maggi to lose $200 mn in brand value

Maggi to lose $200 mn in brand value

Rediff.com18 Jun 2015

Asset valuation consultancy sees brand value slip to $2.2 billion.

'Khalistanis are a microscopic minority in Punjab'

'Khalistanis are a microscopic minority in Punjab'

Rediff.com4 Apr 2023

'The Khalistanis get bulk of the money from abroad.' 'Where did Amritpal's Mercedes come from, which costs well over Rs 60 lakhs?' 'Where does his fleet of vehicles come from?' 'Local Punjabis can certainly not contribute this kind of money.'

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.